A team led by Herng-Ching Lin, PhD, of Taipei Medical University in Taiwan, studied 3,344 patients with nephrolithiasis and compared the 304 patients who underwent PCNL with the 3,040 did not. During a five-year follow-up period, the PCNL-treated patients had a nearly twofold increased risk of being diagnosed with diabetes mellitus compared with the non-PCNL group after adjusting for confounders, the researchers reported online ahead of print in the International Journal of Urology.
In addition, PCNL was associated with a 79% and 71% increased risk of a diabetes mellitus diagnosis compared with extracorporeal shockwave lithotripsy and endoscopic intervention, respectively.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.